Back to Search
STEPHEN HUMBERT, DO
DO
Internal Medicine Physician
NPI: 1871595041IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
OS007256L(PA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE
Class of 1989
Research & Publications (20)
Evaluation of command algorithms for control of upper-extremity neural prostheses.
PMID 12236452·IEEE Trans Neural Syst Rehabil Eng·2002
4-observational
Synaptic localization of p39, a neuronal activator of cdk5.
PMID 10923673·Neuroreport·2000
7-preclinical
p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton.
PMID 10683146·J Cell Sci·2000
7-preclinical
Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death.
PMID 18029446·FASEB J·2008
7-preclinical
Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons.
PMID 18615096·EMBO J·2008
7-preclinical
Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons.
PMID 18772195·Hum Mol Genet·2008
7-preclinical
A member of the maize isopentenyl transferase gene family, Zea mays isopentenyl transferase 2 (ZmIPT2), encodes a cytokinin biosynthetic enzyme expressed during kernel development. Cytokinin biosynthesis in maize.
PMID 18311542·Plant Mol Biol·2008
8-other
Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons.
PMID 17611284·J Neurosci·2007
4-observational
Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation.
PMID 17392473·J Neurosci·2007
7-preclinical
Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.
PMID 16604191·J Clin Invest·2006
7-preclinical
[Cysteamine restores intracellular dynamics and BDNF secretion in Huntington's disease].
PMID 17101082·Med Sci (Paris)·2006
8-other
Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.
PMID 17041811·Cell Mol Life Sci·2006
6-review
Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421.
PMID 16452687·J Neurosci·2006
7-preclinical
Axonal transport failure in neurodegenerative disorders: the case of Huntington's disease.
PMID 15850950·Pathol Biol (Paris)·2005
8-other
Akt is altered in an animal model of Huntington's disease and in patients.
PMID 15845076·Eur J Neurosci·2005
4-observational
Phosphorylation of arfaptin 2 at Ser260 by Akt Inhibits PolyQ-huntingtin-induced toxicity by rescuing proteasome impairment.
PMID 15809304·J Biol Chem·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2510 W TOWNSHIP LINE RD
HAVERTOWN, PA 19083 - Phone
- (484) 450-4500
Quick Facts
- NPI
- 1871595041
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile